MarginsXMarginsX
Home › Markets › Health Care › KARD

Kardigan Inc. (KARD)

KARD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$12.85
-7.02% on the day
Market cap
$1.2B
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerKARD on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2026
SEC CIK0002123613
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

New registrant: no annual report filed under this company yet.

Warning signs

Cash runway
4.4 months
$78.9M cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$70.0M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"As discussed in the Company's audited financial statements for the year ended December 31, 2025, included in the Company's final prospectus dated June 17, 2026, filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, the Company previously concluded that recurring losses, negative cash flows from operations, and limited liquidity raised substantial doubt"
10-Q 2026-11-12
Cash and burn$78.9M cash; operating cash flow -$53.2M a quarter.Report 2026-09-30
Shares outstanding93,597,398 (2026-11-09).Cover page 2026-11-09
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, San Jose, California, United StatesPCAOB Form AP 2026-06-19
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $70.0M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$0-$58.6M-$59.9M$78.9MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q3 2026
2026-06-30
Not filed-$116.2MNot filed$384.0MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q3 2026
2026-03-31
Not filed-$56.1MNot filedNot filedNo debt tagsNeeds four quarters10-Q 2026-11-12
Q3 2026
2025-09-30
Not filed-$60.2M-$46.6M$169.5MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q3 2026
2025-06-30
Not filed-$57.4MNot filed$90.1MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q3 2026
2025-03-31
Not filed-$18.0MNot filedNot filedNo debt tagsNeeds four quarters10-Q 2026-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FINAL PROSPECTUS 424(B)(4)
424B42026-06-18
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12

Source: SEC EDGAR submissions feed, 57 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-11.0%
1 month+6.6%
3 months-36.6%
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high-46.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
OPKOPKO Health Inc.$1.62-3.57%$1.2B
OMEROmeros Corporation$16.68-4.63%$1.2B
SLNSilence Therapeutics Plc American Depository Share$19.80-0.15%$1.2B
CMPSCOMPASS Pathways Plc American Depository Shares$8.27-8.21%$1.2B
AAPGAscentage Pharma Group International American Depository Shares$13.29-9.10%$1.2B
AMPHAmphastar Pharmaceuticals Inc.$29.17-0.68%$1.2B
NKTRNektar Therapeutics$36.44-2.23%$1.2B
MNKDMannKind Corporation$3.96-4.24%$1.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier